Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
On the steps of cell-to-cell HIV transmission between CD4 T cells.
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients.
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.